Document Detail

Cardiovascular disease risk reduction in older adults.
MedLine Citation:
PMID:  16966927     Owner:  NLM     Status:  MEDLINE    
Preventing cardiovascular events in older persons presents unique challenges to clinicians. Cardiovascular disease accounts for a large amount of disability and mortality in older persons. Older persons are often faced with unique and multiple challenges to health, including cognitive decline, social isolation, financial constraints, and physical disabilities. As more and more older persons are enrolled in studies that aim to better understand coronary heart disease and its prevention, new information is becoming available that allow clinicians to improve outcomes in the older adult. The most recent updates in the area of medical management, as well as updates of recommendations for lifestyle changes, including physical activity and dietary recommendations for older persons at risk, are presented in this article.
Linda Klieman; Shauna Hyde; Kathy Berra
Related Documents :
19073367 - The relation of plasma homocysteine to radiographic knee osteoarthritis.
19752877 - The combined effects of overweight and smoking in late adolescence on subsequent disabi...
16388967 - The association of race with frailty: the cardiovascular health study.
18058447 - Do women express and experience psychosis differently from men? epidemiological evidenc...
11798127 - A deliberative method for ranking risks (ii): evaluation of validity and agreement amon...
23356467 - Romantic attachment and relationship functioning in same-sex couples.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Journal of cardiovascular nursing     Volume:  21     ISSN:  1550-5049     ISO Abbreviation:  J Cardiovasc Nurs     Publication Date:    2006 Sep-Oct
Date Detail:
Created Date:  2006-09-12     Completed Date:  2006-09-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703516     Medline TA:  J Cardiovasc Nurs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S27-39     Citation Subset:  IM; N    
Cardiovascular Prevention Programs, Stanford Prevention Research Center, Stanford University School of Medicine, CA 94305-5705, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Antihypertensive Agents / therapeutic use
Antilipemic Agents / therapeutic use
Aspirin / therapeutic use
Behavior Therapy / methods
Cardiovascular Diseases / drug therapy,  etiology,  prevention & control*
Coronary Disease / prevention & control
Diabetes Mellitus, Type 2 / diet therapy
Dyslipidemias / diet therapy,  drug therapy
Exercise Therapy / methods
Fibrinolytic Agents / therapeutic use
Geriatrics / methods*
Hypertension / diet therapy,  drug therapy
Life Style
Obesity / complications,  prevention & control
Primary Prevention / methods*
Risk Assessment / methods
Risk Factors
Smoking Cessation / methods
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 0/Antilipemic Agents; 0/Fibrinolytic Agents; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stroke prevention and management in older adults.
Next Document:  Analysis of measures of functional and cognitive ability for aging adults with cardiac and vascular ...